PHIBRO ANIMAL HEALTH CORP PAHC Cash Flow

Phibro animal health corp (PAHC)

CashFlow / Yearly

Jun'19	Jun'18	Jun'17	Jun'16	Jun'15	Jun'14	Jun'13	Jun'12
OPERATING ACTIVITIES
Net income
54,713	64,883	64,615	82,728	60,280	-3,127	24,891	6,976
Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation and amortization
27,564	26,943	26,001	23,452	21,604	21,453	19,023	17,527
Amortization of debt issuance costs and debt discount
882	883	1,015	989	967	1,448	1,926	-
Stock-based compensation
2,259	334	0	-	-	-	-	-
Acquisition-related items
0	3,908	2,081	-	-	-	-	-
Acquisition-related costs of goods sold
-	-	-	2,566	-	-	-	-
Acquisition-related accrued compensation
-	-	-	1,680	747	-	-	-
Acquisition-related accrued interest
-	-	-	1,476	613	-	-	-
Pension settlement cost
0	0	-1,702	0	0	-	-	-
Amortization of deferred financing costs
-	-	-	-	-	-	-	1,418
Amortization of imputed interest and debt discount
-	-	-	-	-	-	-	327
Deferred income taxes
-105	6,389	-28	-22,244	4,761	1,289	-12,035	-2,392
Foreign currency (gains) losses, net
1,899	635	867	7,725	3,376	-1,429	2,887	3,414
Other
302	-1,181	-765	-354	-61	538	1,438	482
Loss on extinguishment of debt
0	0	-2,598	-	-	-22,771	-	-
Payment of premiums and costs on extinguished debt
-	-	-	-	-	-17,205	-	-
Changes in operating assets and liabilities, net of business acquisitions:
Accounts receivable, net
23,679	11,900	2,765	13,086	1,877	14,683	729	3,775
Inventories, net
20,982	24,292	-5,432	16,439	19,354	3,186	25,106	745
Other current assets
7,173	-134	3,012	-457	-7,416	31	6,526	3,301
Other assets
299	152	1,504	6,547	4,236	-5,103	363	5,792
Accounts payable
12,092	2,446	-3,119	-3,245	4,796	1,682	-6,601	6,410
Accrued interest
-	-	-	-	-	-13,813	33	-104
Accrued expenses and other liabilities
4,098	-114	5,471	-7,198	-3,698	-3,304	5,475	12,507
Net cash provided (used) by operating activities
47,169	70,008	98,385	37,218	68,704	-712	1,437	31,988
Purchases of short-term investments
34,000	82,000	-	-	-	-	-	-
Maturities of short-term investments
60,000	32,000	-	-	-	-	-	-
Capital expenditures
29,891	18,548	20,880	36,352	20,058	19,846	19,947	14,824
Business acquisitions
9,838	15,000	-	46,576	10,377	-	18,692	3,384
Other, net
404	1,064	1,062	-137	4,029	-434	-281	-465
Net cash provided (used) by investing activities
-14,133	-84,612	-21,942	-82,791	-34,464	-19,412	-38,358	-17,743
Revolving credit facility borrowings
213,000	225,000	230,500	255,500	38,000	175,500	75,000	1,000
Revolving credit facility repayments
187,000	220,000	234,500	189,500	35,000	209,500	55,000	4,500
Payments of long-term debt and other
12,649	6,401	285,527	3,929	4,090	335,374	5,201	4,718
Proceeds from long-term debt
-	-	250,000	-	-	289,275	-	-
Issuance of acquisition note payable
3,775	-	-	-	-	-	-	-
Payment of acquisition note payable
3,775	-	-	-	-	-	-	-
Debt issuance costs
-	-	3,925	-	-	4,551	924	-
Proceeds from common shares issued
1,134	5,699	5,541	4,017	1,334	114,429	-	-
Dividends paid
18,592	16,073	15,827	15,708	15,595	25,000	3,000	-
Net cash provided (used) by financing activities
-4,107	-11,775	-53,738	50,380	-15,351	4,779	10,875	-8,218
Effect of exchange rate changes on cash
-524	-536	-227	-418	-1,494	-203	-485	-725
Net increase (decrease) in cash and cash equivalents
28,405	-26,915	22,478	4,389	17,395	-15,548	-26,531	5,302
Supplemental cash flow information
Interest paid
12,250	11,208	14,600	14,215	12,912	45,370	33,824	34,059
Income taxes paid, net
16,215	15,191	14,762	16,828	10,780	12,207	7,061	7,217
Non-cash investing and financing activities
Property, plant and equipment and capital lease additions
2,890	8,449	1,550	1,438	1,193	2,637	103	-
Business acquisition
-	-	-	-	4,156	-	4,550	3,000
Capital / leasehold improvements
-	-	-	-	-	-	-	1,569
Capital lease additions
-	-	-	-	-	-	-	120